Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaletra in HIV/HCV Co-infected Subjects
NCT00234975Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2002
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by AbbVie Inc.. Started Oct 2002; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00234975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234975.